Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery
Published in 2024 by
Kathy S. Albain,
Christina Yau 
,
Emanuel F. Petricoin,
Denise M. Wolf,
Julie E. Lang,
A. Jo Chien,
Tufia Haddad,
Andres Forero-Torres,
Anne M. Wallace,
Henry Kaplan ,
Lajos Pusztai,
David Euhus,
Rita Nanda,
Anthony D. Elias,
Amy S. Clark
and other authors.
,
Emanuel F. Petricoin,
Denise M. Wolf,
Julie E. Lang,
A. Jo Chien,
Tufia Haddad,
Andres Forero-Torres,
Anne M. Wallace,
Henry Kaplan ,
Lajos Pusztai,
David Euhus,
Rita Nanda,
Anthony D. Elias,
Amy S. Clark
and other authors.
